Search

CN

搜索
imgboxbg

Products

>
>
>
>
HemaFus PML-RARA (bcr1, bcr2, and bcr3) Qualitative Detection Kit (PCR-Fluorescent Probing)
HemaFus PML-RARA融合基因bcr1、bcr2和bcr3型定性检测试剂盒(PCR-荧光探针法)_3504x2613 (1)
通用_3783x2660

HemaFus PML-RARA (bcr1, bcr2, and bcr3) Qualitative Detection Kit (PCR-Fluorescent Probing)

Product Introduction Acute promyelocytic leukemia (APL) is a distinct subtype of AML characterized by specific chromosomal translocation (t15;17)(q22;q12) in the vast majority of patients. This leads to the formation of the PML-RARA fusion gene (Figure 1), and its protein product causes cell differentiation arrest and apoptosis deficiency, which is the main molecular mechanism of APL development.
Cat. No.:
J0366
Spec:
24 Tests/Kit
HemaFus PML-RARA融合基因bcr1、bcr2和bcr3型定性检测试剂盒(PCR-荧光探针法)_3504x2613 (1)
通用_3783x2660
Product description
Parameters

Background

 

Acute promyelocytic leukemia (APL) is a distinct subtype of AML characterized by specific chromosomal translocation (t15;17)(q22;q12) in the vast majority of patients. This leads to the formation of the PML-RARA fusion gene (Figure 1), and its protein product causes cell differentiation arrest and apoptosis deficiency, which is the main molecular mechanism of APL development.

 

 

 

Figure 1

 

PML/RARA fusion gene is heterogeneous. Since PML gene recombination occurs in different breakpoint cluster regions, three isoforms have been identified (Figure 2): (1) Long isoform (L; bcr-1) caused by a breakpoint in PML resulting in fusion of RARA (exon 3) with PML (exon 6); (2) Variant isoform (V; bcr-2). Caused by a breakpoint in PML resulting in fusion of RARA (exon 3) with PML (exon 6); (3) Short isoform (S; bcr-3), caused by  a breakpoint in PML resulting in fusion of RARα (exon 3) with PML (exon 3). The PML/RARα fusion gene is highly correlated with M3, and its detection results are helpful for the diagnosis of M3.

 

 

 

 

Figure 2

 

Detection Process

 

In this method, RNA is isolated and purified from leukocytes in peripheral blood or bone marrow samples, and cDNA is obtained by reverse transcription to detect bcr1, bcr2, and bcr3 types of PML-RARA fusion gene by real-time Q-PCR. PML-RARA fusion is shown in Figure 3.

 

 

Figure 3

 

Quantitative Kit Detection Results

 

 

 

Specimen Requirements

 

Peripheral blood or bone marrow (3–5 mL) is collected in the EDTA tube and stored at 2–8 °C for not more than 5 days. RNA extraction is performed within 5 days.

 

 

References

 

[1] NCCN Clinical Practice Guidelines in Oncology: Acute Myeloid Leukemia (version 3.2017)

 

[2] Leukemia,2003,17(12):2318-2357

 

[3] Leukemia(1999)13,1901-1928.

 

 

 

Ordering Information

 

Cat. No. Product Strength

T0305

 

HemaFus PML-RARa(bcr1) Quantitative Detection Kit
(PCR-fluorescence probing)

 

24 Tests/Kit

T0306

 

HemaFus PML-RARa(bcr2) Quantitative Detection Kit
(PCR-fluorescence probing)

 

24 Tests/Kit

T0307

 

HemaFus PML-RARa(bcr3) Quantitative Detection Kit
(PCR-fluorescence probing)

 

24 Tests/Kit

 

 

Scan the QR code to read on your phone
We could not find any corresponding parameters, please add them to the properties table

Copyright:Wuhan Healthy Biotechnology Co., Ltd.